secwatch / observer
8-K filed October 14, 2022, 7:59 PM ET ticker CNTA CIK 0001847903
leadership confidence high sentiment neutral materiality 0.45

Centessa CMO Javad Shahidi departs; Antoine Yver assumes responsibilities effective Oct 14, 2022

Centessa Pharmaceuticals plc

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Antoine Yver

Chief Medical Officer
CNTA · Centessa Pharmaceuticals plc
Effective
2022-10-14
Filed
October 14, 2022, 7:59 PM ET
Antoine Yver, M.D., M.Sc., Chairman of Development of the Company, will assume all responsibilities currently held by Dr. Shahidi effective October 14, 2022.
Departed

Javad Shahidi

Chief Medical Officer
CNTA · Centessa Pharmaceuticals plc
Effective
2022-10-14
Successor
Antoine Yver
Filed
October 14, 2022, 7:59 PM ET
On October 13, 2022, Centessa Pharmaceuticals plc (the “Company”) and Javad Shahidi, M.D., M.Sc., Chief Medical Officer, mutually agreed that Dr. Shahidi will be departing from the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Antoine Yver changed role as Chief Medical Officer at Centessa Pharmaceuticals plc.

Action
assumed responsibilities
Role
Chief Medical Officer
Exact text from the filing
Antoine Yver, M.D., M.Sc., Chairman of Development of the Company, will assume all responsibilities currently held by Dr. Shahidi effective October 14, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Javad Shahidi departed as Chief Medical Officer at Centessa Pharmaceuticals plc.

Action
mutually agreed to depart
Role
Chief Medical Officer
Exact text from the filing
On October 13, 2022, Centessa Pharmaceuticals plc (the “Company”) and Javad Shahidi, M.D., M.Sc., Chief Medical Officer, mutually agreed that Dr. Shahidi will be departing from the Company.
View on SEC.gov

Centessa Pharmaceuticals plc filing history →

Source: SEC EDGAR
accession 0001847903-22-000071
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.